SEC Form 4 · accession 0001013762-15-000988
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Bacha
Officer — President, CEO · Director · 10% Owner
Period of report
Oct 8, 2015
Accepted (ET)
Oct 9, 2015 · 11:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 8, 2015 | P | 2,800 | $0.7999 | A | 130,285 | D | |
| Common Stock | Oct 8, 2015 | P | 200 | $0.78 | A | 130,485 | D |
Table II — derivative securities
No Table II lines on this filing.